OncoFusion Therapeutics
Ann Arbor
About OncoFusion Therapeutics
OncoFusion Therapeutics Inc. discovers and develops personalized therapeutics for patients with genetically defined cancers. It focuses on bromodomain inhibitors, ERG inhibitors, EZH-2-EED inhibitors, and MMSET/NSD 2 inhibitors. The company was founded in 2012 and is based in Ann Arbor, Michigan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $525.0K
- Last round: Debt Financing (Mar 2013)
- Website: oncofusion.com
- Phone: 48109-2590
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/oncofusion-therapeutics-2891861 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.